Taken together, these results suggest that the loss of CD2AP in podocytes causes podocyte injury (identified by foot process effacement on electron microscopy), drives pathogenic podocyte-mesangial crosstalk, ultimately leading to glomerular volume expansion, podocyte depletion and progressive glomerular disease progression. The gene discussed is CD2AP; the disease is glomerular disorder.